|
|
||||||||
1Signal Transduction Laboratory, Departments of Anesthesiology and Internal Medicine, and 2Department of Physiology and Mayo Clinic and Foundation, Rochester, Minnesota 55905; and 3Trudeau Institute, Saranac Lake, New York 12983
Submitted 11 March 2004 ; accepted in final form 16 August 2004
Oxytocin-induced Ca2+ transients play an important role in myometrial contractions. Here, using a knockout model, we found that the enzyme CD38, responsible for the synthesis of the second messenger cyclic ADP-ribose (cADPR), plays an important role in the oxytocin-induced Ca2+ transients and contraction. We also observed that CD38 is necessary for TNF-
-increased agonist-stimulated Ca2+ transients in human myometrial cells. We provide experimental evidence that the TNF-
effect is mediated by increased expression of the enzyme CD38. First, we observed that TNF-
increased oxytocin-induced Ca2+ transients and CD38 expression in human myometrial cells. Moreover, using small interference RNA technology, we observed that TNF-
stimulation of agonist-induced Ca2+ transients was abolished by blocking the expression of CD38. In control experiments, we observed that activation of the component of the TNF-
signaling pathway, NF-
B, was not affected by the treatments. Finally, we observed that the effects of TNF-
on CD38 cyclase and oxytocin-induced Ca2+ transients are abolished by progesterone. In conclusion, we provide the first experimental evidence that CD38 is important for myometrial Ca2+ transients and contraction. Moreover, CD38 is necessary for the TNF-
-mediated augmentation of agonist-induced Ca2+ transients in myometrial cells. We propose that the balance between cytokines and placental steroids regulates the expression of CD38 in vivo and cell responsiveness to oxytocin.
cyclic adenosine diphosphate-ribose; small interference ribonucleic acid; endoplasmic reticulum; ryanodine channel; tumor necrosis factor-
This article has been cited by other articles:
![]() |
G. C. Sieck, T. A. White, M. A. Thompson, C. M. Pabelick, M. E. Wylam, and Y. S. Prakash Regulation of store-operated Ca2+ entry by CD38 in human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L378 - L385. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. P. Barbosa, S. M. Soares, C. M. Novak, D. Sinclair, J. A. Levine, P. Aksoy, and E. N. Chini The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity FASEB J, November 1, 2007; 21(13): 3629 - 3639. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dabertrand, N. Fritz, J. Mironneau, N. Macrez, and J.-L. Morel Role of RYR3 splice variants in calcium signaling in mouse nonpregnant and pregnant myometrium Am J Physiol Cell Physiol, September 1, 2007; 293(3): C848 - C854. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Soares, M. Thompson, T. White, A. Isbell, M. Yamasaki, Y. Prakash, F. E. Lund, A. Galione, and E. N. Chini NAADP as a second messenger: neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells Am J Physiol Cell Physiol, January 1, 2007; 292(1): C227 - C239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Johnson, E. L. Ford, E. Bernal-Mizrachi, K. L. Kusser, D. S. Luciani, Z. Han, H. Tran, T. D. Randall, F. E. Lund, and K. S. Polonsky Suppressed insulin signaling and increased apoptosis in CD38-null islets. Diabetes, October 1, 2006; 55(10): 2737 - 2746. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Lund, H. Muller-Steffner, H. Romero-Ramirez, M. E. Moreno-Garcia, S. Partida-Sanchez, M. Makris, N. J. Oppenheimer, L. Santos-Argumedo, and F. Schuber CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism Int. Immunol., July 1, 2006; 18(7): 1029 - 1042. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |